Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will host a virtual Investor Day on Wednesday, January 21, 2026.
The event will offer investors and analysts an in-depth look at the Company’s long-term strategy, product roadmap, and financial outlook, as well as a Q&A session with the executive leadership team.
“Biopharma companies are rethinking how they develop medicines—prioritizing greater predictability, transparency, and scientific rigor at every step. Simulations Plus sits at the intersection of these needs,” said Shawn O’Connor, Chief Executive Officer of Simulations Plus. “We are committed to helping our clients navigate this complexity with clarity and confidence. During Investor Day, we will demonstrate how our unified strategy positions us to support the next era of innovation in drug development.”
Attendees will gain insight into Simulations Plus’ vision for an integrated, AI-enabled modeling ecosystem spanning discovery, development, clinical operations, and commercialization. The agenda will include updates on:
- The industry environment and the accelerating adoption of model-informed drug development (MIDD)
- The Company’s unified product and technology strategy
- Advances in scientific services supporting client workflows across the drug lifecycle
- Financial priorities and outlook
The event will be webcast live, and a replay will be posted following the event.
Event Details
- Date: Wednesday, January 21, 2026
- Time: 1:00 PM ET – 2:30 PM ET
- Location: Virtual
- Webcast Registration: Here